News
-
-
-
COMMUNIQUÉ DE PRESSE
Inside Information / News release on accounts, results
GenSight Biologics reports cash position of €6.9 million as of June 30, 2024, with potential over 100 vials available upon Q3 resumption of early access program. Company confirms sufficient working capital and successful blending step for LUMEVOQ drug product -
-
COMMUNIQUÉ RÉGLEMENTÉ
Thales publie ses résultats semestriels 2024
-
COMMUNIQUÉ RÉGLEMENTÉ
Thales reports its 2024 half-year results
-
COMMUNIQUÉ DE PRESSE
Julius Baer appoints Stefan Bollinger as Chief Executive Officer
Julius Baer appoints Stefan Bollinger, Partner at Goldman Sachs, as new CEO starting in early 2025, following a comprehensive search. Bollinger brings 3 decades of experience in financial markets and global banking -
-
-
COMMUNIQUÉ DE PRESSE
FORVIA HELLA publishes half-year results 2024: Slight improvement in sales and earnings in a challenging market environment
FORVIA HELLA reports slight sales and earnings improvement in H1 2024 despite challenging market conditions. Detailed financial results and outlook provided
